SmartCardia gets impressive media coverage with wireless patch

SmartWearable is a cordless wearable medical multi-sensor monitoring system. Key innovation developed by SmartCardia, it has received on March 9^th a CE Class IIa certification. In a world where real-time data is invaluable for doctors to treat patients as accurately as possible, this device provides continuous monitoring and analysis of vital signs, allowing for early warning of a health risk. In an emergency-room setting, it can continuously measure physiological and vital parameters such as Electrocardiogram (ECG), heart rate, pulse rate, oxygen saturation (SpO2), blood pressure, and skin temperature, all within a small unit with the same accuracy as existing systems using cumbersome cables. Small and wireless, it has been miniaturized to be the size of a Band-Aid. Equipped with artificial intelligence, the patch records, monitors and analyzes vital signs fluctuations, allowing for real-time predictions. For example, applied to the skin, it can predict a heart attack before it happens.
Equipment currently used in hospitals, although efficient, is voluminous and requires wires making patients uneasy. With this small unit, patients can resume day-to-day activity and can continue to be monitored from home. 

The EPFL spin-off, based in the Innovation Park at the EPFL, is a Swiss medical device company with focus on clinical quality data and validation. Before its incorporation, SmartCardia participated in Venture Kick. Following conclusive tests on hundreds of patients in different hospitals and the certification announcement, the startup is now moving to production and will soon launch the device on the Swiss and EU markets. This new milestone has been relayed in more than 12 newspapers. Among them were general newspapers like le 24 heures, Agefi and technical blogs such as The Daily Dot, the Tech Explorist or ECN Mag. Read the articles below.